ReP USP - Resultado da busca

Filtros : "Polônia" "Cocco, Lucio" Removidos: "CARVALHO, CLAUDIO ANTONIO FERRAZ DE" "Indexado no : Science Citation Index Expanded" "Koszmider, Piotr" "Program Book" Limpar

Filtros

Language
- inglês (~2)
Source title
- advances in biological regulation (~2)
Publisher
Conference titles
Countries/Territories
- holanda (~2)
Grupo de pesquisa
Funding Agencies
- financiamento ecu (~2)
- financiamento intesa san paolo fondazione (~2)
- financiamento lilt (~1)
- financiamento ncn (~1)
Indexado em
Collaboration
Normalized affiliation
Non normalized affiliation
- department of physiological sciences. piracicaba dental school. state university of campinas. piracicaba, sp (2)
- catholic fu jen university hospital. new taipei city (1)
- center of comparative medicine and pathology. memorial sloan-kettering cancer center. weill cornell medicine and the hospital for special surgery. new york city, new york (1)
- college of basic medical sciences. dalian medical university. dalian, liaoning (1)
- consiglio nazionale delle ricerche. istituto di biomedicina e immunologia molecolare \201calberto monroy\201d. palermo (1)

Countries of institutions of collaboration
- brasil (2)
- estados unidos (2)
- itália (2)
- polônia (2)
- austrália (1)

Artigo de periodico
Abilities of β-Estradiol to interact with chemotherapeutic drugs, signal transduction inhibitors and nutraceuticals and alter the proliferation of pancreatic cancer cells (2020)
Akula, Shaw M; Candido, Saverio; Abrams, Stephen L; Steelman, Linda S; Lertpiriyapong, Kvin; Cocco, Lucio; Ramazzotti, Giulia; Ratti, Stefano; Follo, Matilde Y; Martelli, Alberto M; Murata, Ramiro M; Rosalen, Pedro L; Bueno-Silva, Bruno; Alencar, Severino Matias de ; Falasca, Marco; Montalto, Giuseppe; Cervello, Melchiorre; Notarbartolo, Monica; Gizak, Agnieszka; Rakus, Dariusz; Libra, Massimo; McCubrey, James A
Source: Advances in Biological Regulation. Unidade: ESALQ
Subjects: ESTRADIOL, NEOPLASIAS PANCREÁTICAS, PRODUTOS NATURAIS, QUIMIOTERÁPICOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
AKULA, Shaw M et al. Abilities of β-Estradiol to interact with chemotherapeutic drugs, signal transduction inhibitors and nutraceuticals and alter the proliferation of pancreatic cancer cells. Advances in Biological Regulation, v. 75, p. 1-15, 2020Tradução . . Disponível em: https://doi.org/10.1016/j.jbior.2019.100672. Acesso em: 15 nov. 2024.
APA
Akula, S. M., Candido, S., Abrams, S. L., Steelman, L. S., Lertpiriyapong, K., Cocco, L., et al. (2020). Abilities of β-Estradiol to interact with chemotherapeutic drugs, signal transduction inhibitors and nutraceuticals and alter the proliferation of pancreatic cancer cells. Advances in Biological Regulation, 75, 1-15. doi:10.1016/j.jbior.2019.100672
NLM
Akula SM, Candido S, Abrams SL, Steelman LS, Lertpiriyapong K, Cocco L, Ramazzotti G, Ratti S, Follo MY, Martelli AM, Murata RM, Rosalen PL, Bueno-Silva B, Alencar SM de, Falasca M, Montalto G, Cervello M, Notarbartolo M, Gizak A, Rakus D, Libra M, McCubrey JA. Abilities of β-Estradiol to interact with chemotherapeutic drugs, signal transduction inhibitors and nutraceuticals and alter the proliferation of pancreatic cancer cells [Internet]. Advances in Biological Regulation. 2020 ; 75 1-15.[citado 2024 nov. 15 ] Available from: https://doi.org/10.1016/j.jbior.2019.100672
Vancouver
Akula SM, Candido S, Abrams SL, Steelman LS, Lertpiriyapong K, Cocco L, Ramazzotti G, Ratti S, Follo MY, Martelli AM, Murata RM, Rosalen PL, Bueno-Silva B, Alencar SM de, Falasca M, Montalto G, Cervello M, Notarbartolo M, Gizak A, Rakus D, Libra M, McCubrey JA. Abilities of β-Estradiol to interact with chemotherapeutic drugs, signal transduction inhibitors and nutraceuticals and alter the proliferation of pancreatic cancer cells [Internet]. Advances in Biological Regulation. 2020 ; 75 1-15.[citado 2024 nov. 15 ] Available from: https://doi.org/10.1016/j.jbior.2019.100672
Artigo de periodico
Effects of the MDM-2 inhibitor Nutlin-3a on PDAC cells containing and lacking WT-TP53 on sensitivity to chemotherapy, signal transduction inhibitors and nutraceuticals (2019)
Candido, Saverio; Abrams, Stephen L; Steelman, Linda S; Lertpiriyapong, Kvin; Martelli, Alberto M; Cocco, Lucio; Ratti, Stefano; Follo, Matilde Y; Murata, Ramiro M; Rosalen, Pedro L; Bueno-Silva, Bruno; Alencar, Severino Matias de ; Lombardi, Paolo; Mao, Weifeng; Montalto, Giuseppe; Cervello, Melchiorre; Rakus, Dariusz; Gizak, Agnieska; Lin, Heng-Liang; Libra, Massimo; Akula, Shaw M; McCubrey, James A
Source: Advances in Biological Regulation. Unidade: ESALQ
Subjects: NEOPLASIAS PANCREÁTICAS, QUIMIOTERAPIA, TERAPÊUTICA MÉDICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CANDIDO, Saverio et al. Effects of the MDM-2 inhibitor Nutlin-3a on PDAC cells containing and lacking WT-TP53 on sensitivity to chemotherapy, signal transduction inhibitors and nutraceuticals. Advances in Biological Regulation, v. 72, p. 22-40, 2019Tradução . . Disponível em: https://doi.org/10.1016/j.jbior.2019.03.002. Acesso em: 15 nov. 2024.
APA
Candido, S., Abrams, S. L., Steelman, L. S., Lertpiriyapong, K., Martelli, A. M., Cocco, L., et al. (2019). Effects of the MDM-2 inhibitor Nutlin-3a on PDAC cells containing and lacking WT-TP53 on sensitivity to chemotherapy, signal transduction inhibitors and nutraceuticals. Advances in Biological Regulation, 72, 22-40. doi:10.1016/j.jbior.2019.03.002
NLM
Candido S, Abrams SL, Steelman LS, Lertpiriyapong K, Martelli AM, Cocco L, Ratti S, Follo MY, Murata RM, Rosalen PL, Bueno-Silva B, Alencar SM de, Lombardi P, Mao W, Montalto G, Cervello M, Rakus D, Gizak A, Lin H-L, Libra M, Akula SM, McCubrey JA. Effects of the MDM-2 inhibitor Nutlin-3a on PDAC cells containing and lacking WT-TP53 on sensitivity to chemotherapy, signal transduction inhibitors and nutraceuticals [Internet]. Advances in Biological Regulation. 2019 ; 72 22-40.[citado 2024 nov. 15 ] Available from: https://doi.org/10.1016/j.jbior.2019.03.002
Vancouver
Candido S, Abrams SL, Steelman LS, Lertpiriyapong K, Martelli AM, Cocco L, Ratti S, Follo MY, Murata RM, Rosalen PL, Bueno-Silva B, Alencar SM de, Lombardi P, Mao W, Montalto G, Cervello M, Rakus D, Gizak A, Lin H-L, Libra M, Akula SM, McCubrey JA. Effects of the MDM-2 inhibitor Nutlin-3a on PDAC cells containing and lacking WT-TP53 on sensitivity to chemotherapy, signal transduction inhibitors and nutraceuticals [Internet]. Advances in Biological Regulation. 2019 ; 72 22-40.[citado 2024 nov. 15 ] Available from: https://doi.org/10.1016/j.jbior.2019.03.002

Digital Library of Intellectual Production of Universidade de São Paulo 2012 - 2024